SELEX-HTCFQプラットフォーム:ZBP1依存免疫病変抑制のためのADAR1のDNA強化剤の開発
Yusi Hu1,2, Rentang Huang2, Yi-Fan Wang2
1Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, International Joint Research Center of Human-Machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province, School of Pharmacy, Hainan Medical University, Haikou 571199, P. R. China.
Journal of the American Chemical Society
|November 21, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.3K
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
1.8K
